Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
The ETS gene family is frequently involved in chromosome translocations that cause human cancer, including prostate cancer, leukemia, and sarcoma. However, the mechanisms by which oncogenic ETS proteins, which are DNA-binding transcription factors, target genes necessary for tumorigenesis is not well understood. Ewing's sarcoma serves as a paradigm for the entire class of ETS-associated tumors because nearly all cases harbor recurrent chromosomal translocations involving ETS genes. The most common translocation in Ewing's sarcoma encodes the EWS/FLI oncogenic transcription factor. We used whole genome localization (ChIP-chip) to identify target genes that are directly bound by EWS/FLI. Analysis of the promoters of these genes demonstrated a significant over-representation of highly repetitive GGAA-containing elements (microsatellites). In a parallel approach, we found that EWS/FLI uses GGAA microsatellites to regulate the expression of some of its target genes including NR0B1 , a gene required for Ewing's sarcoma oncogenesis. The microsatellite in the NR0B1 promoter bound EWS/FLI in vitro and in vivo and was both necessary and sufficient to confer EWS/FLI regulation to a reporter gene. Genome wide computational studies demonstrated that GGAA microsatellites were enriched close to EWS/FLI-up-regulated genes but not down-regulated genes. Mechanistic studies demonstrated that the ability of EWS/FLI to bind DNA and modulate gene expression through these repetitive elements depended on the number of consecutive GGAA motifs. These findings illustrate an unprecedented route to specificity for ETS proteins and use of microsatellites in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nine ETS proteins have been assayed for genome-wide occupancy by either promoter microarrays (ETS1, GABPA, ELF1, ELK1, EWS-FLI1, and SPI1) (132–135) or high-throughput sequencing (GABPA, ETS1, ERG, FLI1, EWS-ERG, EWS-FLI1, SPI1, SPDEF, ETV1, and ELF1) (29, 62, 65, 136–140).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
In the citing paper
“Of these two classes of target sequences, only genes near the microsatellite repeats correlate with expression changes associated with transformation, including NROB1 (133) and GSTM4 (186).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
In the citing paper
“ChIP-chip and ChIP-Seq have identified the genomic regions bound by the most common ETS fusion proteins in Ewing’s sarcoma, EWS-FLI1 and EWS-ERG (62, 133, 137).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
In the citing paper
“In fact, four or more repeats are necessary for EWS-FLI1 transcriptional activation in reporter assays, and two EWS-FLI1 monomers bind to this four-motif array in biochemical assays (Figure 7) (133, 137, 187).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [133]
Citations
Cites
Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
Bailey, T. L., & Elkan, C. (1994) · PubMed · Cited by 5,806
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
US Department of Health and Human Services; National Cancer Institute (1999) · PsycEXTRA Dataset · doi:10.1037/e407432005-001 · Cited by 1,947
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907 · cited 2×
“Ewing’s sarcoma is a highly malignant solid tumor of children and young adults that usually harbors a recurrent chromosomal translocation, t(11;22)(q24;q12), that encodes the EWS/FLI fusion oncoprotein (10).”
BackgroundThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086 · cited 1×
“Most members of the ETS family bind to DNA sequences containing a GGAA (or in some cases, GGAT) core motif, with sequences flanking the GGAA core contributing to the affinity and specificity of the interaction (3, 6, 7).”
BackgroundCentre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574
Self-citationMay, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
Self-citationETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469
Research works printed but not linked: 2
- 10.1128/mcb.13.12.7393-7398.1993 · doi:10.1128/mcb.13.12.7393-7398.1993 · Paper page
- ME Gillespie A structural and genetic investigation of DNA binding by the murine Ets-1 Ets domain a winged HTH transcription factor. (University of Utah Salt Lake City PhD thesis. (1998).
Cited by
Items 201–298 of 298
Chong, S., Dugast‐Darzacq, C., Liu, Z. J., Dong, P., Dailey, G. M., Cattoglio, C., Banala, S., Lavis, L. D., Darzacq, X., & Tjian, R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/208710 · Cited by 9
“4D), including CAV1, FCGRT, ABHD6, KDSR and KIAA1797 (30, 35).”
MethodMolnar, C., Reina, J., Herrero, A., Heinen, J. P., Méndiz, V., Bonnal, S., Irimia, M., Sánchez-Jiménez, M., Sánchez-Molina, S., Mora, J., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac222 · Cited by 10
“GGAAμSats of around 20 GGAA repeats are best suited as EWS-FLI responsive elements (4, 5, 7, 44, 63).”
BackgroundGenomic tools for dissecting oncogenic transcriptional networks in human leukemia
Palomero, T., & Ferrando, A. A. (2009) · Leukemia · doi:10.1038/leu.2008.394 · Cited by 9
Molecular genetics of Ewing sarcoma, model systems and finding novel (immuno-) therapeutic targets
van der Ent, W., Sand, L. G. L., & Hogendoorn, P. C. W. (2018) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2018.09 · Cited by 7
“In addition to classic ETS transcription factor binding sites, EWSR1-FLI1 preferentially binds to such stretches of GGAA repeats, where its activity increases with the increase of amount of repeats([36,37]).”
BackgroundLombardi, S., Zilocchi, M., Nicsanu, R., & Barabino, S. M. L. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103846 · Cited by 7
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma
Figuerola-Bou, E., Ríos-Astorch, C., Blanco, E., Sánchez-Jiménez, M., Táboas, P., Fernández, G., Gómez‐González, S., Muñoz, O., Castellano‐Escuder, P., Pérez‐Jaume, S., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3452 · Cited by 7
“EWSR1::FLI1 exhibits a high affinity for binding DNA through GGAA motifs, a class of ETS-specific response elements, activating or repressing their targets based on the number of motif repeats (14, 15).”
Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma
Suresh, V., Hafemeister, C., Konstantinou, A., Grissenberger, S., Sturtzel, C., Cidre‐Aranaz, F., Wenninger-Weinzierl, A., Zylka, M. M., Queiroz, K. C. S., Kurek, D., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00364-7 · Cited by 13
“Notably, cluster G5 includes several well-characterized GGAA microsatellite-driven genes such as BCL11B , CCND1 , NKX2-2 , NPY1R, NR0B1 , and POU3F1 (Gangwal et al, 2008; Garcia-Aragoncillo et al, 2008).”
Phase-separating fusion proteins drive cancer by upsetting transcription regulation
Farahi, N., Lázár, T., Tompa, P., Mészáros, B., & Pancsa, R. (2025) · Genome biology · doi:10.1186/s13059-025-03787-0 · Cited by 6
“Therefore, such fusions resolve both the gene regulatory restraints and LLPS dependencies of the incorporated TFs and form condensates along the DNA even at genes that are not normally regulated by the TF [78, 104, 105].”
Vital, T., Wali, A., Butler, K. V., Xiong, Y., Foster, J. P., Marcel, S. S., McFadden, A. W., Nguyen, V. U., Bailey, B. M., Lamb, K. N., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1099550 · Cited by 6
“contributes its DNA binding domain to the chimeric oncoprotein, EWSR1::FLI1 is largely retargeted to microsatellite repeats of the core ETS motif, (GGAA)n (5, 6).”
BackgroundMahnoor, S., Molnar, C., Velázquez, D., Reina, J., Llamazares, S., Heinen, J. P., Mora, J., & González, C. (2024) · Open Biology · doi:10.1098/rsob.240043 · Cited by 6
“To further characterize the new full-length EWS-FLI 1 lines, we quantified the efficiency of each transgene at activating transcription from GGAAµSats, which is one of the hallmarks of the EWS-FLI 1 oncogene and is known to be critical for EwS tumorigenesis [9,18,28,29].”
MethodEwing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease
Simmons, O., Maples, P. B., Senzer, N. N., & Nemunaitis, J. J. (2012) · ISRN Oncology · doi:10.5402/2012/247657 · Cited by 6
Kumar, S., Mokhtari, R. B., Yeger, H., & Baruchel, S. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.722077 · Cited by 6
“Attempts to develop GEMM for Ewing’s sarcoma have been unsuccessful [32].”
Taipale, J. (2018) · Science · doi:10.1126/science.aav3494 · Cited by 6
Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas
Petrescu, D. I., Yustein, J. T., & Dasgupta, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1388484 · Cited by 5
Dupuy, M., Guéguinou, M., Postec, A., Brion, R., Tesfaye, R. A., Mullard, M., Regnier, L., Amiaud, J., Hubsch, C., Potier‐Cartereau, M., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03199-7 · Cited by 6
“It has also been proven that EWS::FLI1 is able to bind GGAA microsatellites [32, 33], which can be repeated up to 20 times.”
Uchiumi, F., Larsen, S. H., & Tanum, S.-I. (2013) · InTech eBooks · doi:10.5772/53905 · Cited by 6
Kitagawa, T., Kobayashi, D., Baron, B., Okita, H., Miyamoto, T., Takai, R., Paudel, D., Ohta, T., Asaoka, Y., Tokunaga, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269077 · Cited by 6
“The NR0B1 gene harbors EWS-FLI1-bound GGAA microsatellites within its promoter region [35].”
BackgroundNext steps in Ewing sarcoma (epi-)genomics
Sannino, G., Orth, M. F., & Grünewald, T. G. P. (2017) · Future Oncology · doi:10.2217/fon-2017-0159 · Cited by 5
Microsatellite enhancers can be targeted to impair tumorigenesisPreprint
Kaeding, K. E., & Zaret, K. S. (2018) · Genes & Development · doi:10.1101/gad.318105.118 · Cited by 5
“In Ewing sarcoma, the second most common pediatric bone cancer, active enhancer-like GGAA repeats are a hallmark of the disease (Gangwal et al. 2008).”
BackgroundLinking germline and somatic variation in Ewing sarcoma
Gomez, N. C., & Davis, I. J. (2015) · Nature Genetics · doi:10.1038/ng.3387 · Cited by 4
The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers
Monovich, A. C., Gurumurthy, A., & Ryan, R. J. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_13 · Cited by 4
Davis, I. J., & Pattenden, S. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812433-8.00003-4 · Cited by 5
Microsatellite Repeats: Canaries in the Coalmine
Chatterjee, N., Santillan, B. A., & Wilson, J. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6280-4_7 · Cited by 7
Truong, D. D., Lamhamedi-Cherradi, S.-E., Porter, R. W., Krishnan, S., Swaminathan, J., Gibson, A., Lazar, A. J., Livingston, J. A., Gopalakrishnan, V., Gordon, N. B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.21.476982 · Cited by 4
Caltavituro, A., Buonaiuto, R., Pietroluongo, E., Morra, R. P., Salomone, F., Placido, P. D., Pagliuca, M., Vaia, A., Ottaviano, M., Tortora, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030874 · Cited by 4
Targeting epigenetic aberrations of sarcoma in CRISPR era
Tanaka, M., & Nakamura, T. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23142 · Cited by 4
Germline Variation and Somatic Alterations in Ewing Sarcoma
Machiela, M. J., & Grünewald, T. G. P. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_1 · Cited by 3
Systems Biology Analysis for Ewing Sarcoma
Petrizzelli, M., Merlevede, J., & Zinovyev, A. Y. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_23 · Cited by 4
Biological Functions of the Duplicated GGAA-motifs in Various Human Promoter Regions
Uchiumi, F., Miyazaki, S., & Tanuma, S.-I. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.1787 · Cited by 4
Selig, E. E., Moreno-Romero, A. K., Akula, S., Xu, X., & Libich, D. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.04.494830 · Cited by 5
Goodspeed, A. E., Bodlak, A., Duffy, A. B., Nelson-Taylor, S., Oike, N., Porfilio, T. E., Shirai, R., Walker, D., Treece, A. L., Black, J. O., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.18.576251 · Cited by 3
McGinnis, J. H., Bremauntz, A. E., Vandiver, F., Bai, X. L., Kim, J., Kilgore, J. A., Saha, P., O’Hara, R. A., Xie, Y., Banaszynski, L. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.27.620498 · Cited by 4
Suresh, V., Hafemeister, C., Konstantinou, A., Grissenberger, S., Sturtzel, C., Cidre‐Aranaz, F., Wenninger-Weinzierl, A., Zylka, M. M., Queiroz, K. C. S., Kurek, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.03.647002 · Cited by 3
Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy
Mancarella, C., & Scotlandi, K. (2024) · Journal of Clinical Oncology · doi:10.1200/jco-24-01323 · Cited by 2
Dupuy, M., Postec, A., Mullard, M., Chantôme, A., Hulin, P., Brion, R., Guéguinou, M., Regnier, L., Potier‐Cartereau, M., Royer, B. B.-L., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01981-4 · Cited by 3
“These fusion proteins have been shown to regulate many genes [34], including transcription factors, such as NR0B1 [35, 36], or other proteins involved in tumorigenesis, like LOXDH1 [37], by binding at GGAA microsatellites repetitions [35, 38].”
Kaufman, R., Flores, G., Boguslawski, E. A., Kinn-Gurzo, S. S., Chassé, M. H., Beddows, I., Adams, M., Stout, M. C., Gaetano, L. M., Lopez, R. D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69488-9 · Cited by 2
“4b) 14,33,46 – 48 .”
Chen, Z., Arai, E., Khan, O., Zhang, Z., Ngiow, S. F., He, Y. M., Huang, H., Manne, S., Cao, Z., Baxter, A. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.20.087379 · Cited by 2
“Moreover, the oncogenic EWS-FLI1 fusion protein can bind genomic microsatellites (Gangwal et al., 2008), trigger de novo enhancer formation via chromatin remodeling and inactivate existing enhancers by displacing ETS family members (Riggi et al., 2014).”
BackgroundBayanjargal, A., Taslim, C., Showpnil, I. A., Selich‐Anderson, J., Crow, J. C., Lessnick, S. L., & Theisen, E. R. (2024) · eLife · doi:10.7554/elife.95626.2 · Cited by 3
Self-citationSystematic evaluation of the impact of promoter proximal short tandem repeats on expressionPreprint
Zhang, X., Lingzhi, Z., Wang, E., Benton, S. M., Modolo, E., Maksimov, M., Shleizer-Burko, S., Gong, Q., Wang, C., Lamkin, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.14.676153 · Cited by 4
Undifferentiated Small Round Cell Sarcomas of Bone
Makise, N., & Yoshida, A. (2025) · Surgical pathology clinics · doi:10.1016/j.path.2025.01.001 · Cited by 1
Structure and cooperative formation of a FLI1 filament on contiguous GGAA DNA sites
Hou, C., & Tsodikov, O. V. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf205 · Cited by 6
“The size of an EWS–FLI1–DNA complex in vitro increases with the increasing number of contiguous GGAA sites in DNA oligomers of the same size, indicating that multiple copies of EWS–FLI1 are bound to these DNA ligands and, by inference, to GGAA microsatellites [ 21 ].”
InfluentialVidavski, M., Brodsky, S., Manadre, W., Jana, T., Mindel, V., Navon, Y., & Barkai, N. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101349 · Cited by 1
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Grohar, P. J., Heise, R. S., Wedekind, M. F., Ballman, K. V., Mascarenhas, L., DuBois, S. G., Maki, R. G., Boguslawski, E. A., Gedminas, J. M., Wilson, E. R., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04340-7 · Cited by 1
“A composite feature list was generated by literature review of 10 well-established EWS::FLI1 target genes associated with GGAA microsat-ellites: NR0B1 , IL1RAP , EZH2 , CAV1 , AKAP7 , CACNB2 , RCOR1 , FCGRT , FEZ-F1 and FOCAD 12,39–42 .”
InfluentialDynamic Regulation of Endogenous Transcription Factor Hubs at Single‐Molecule Resolution
Yoshida, S. R., Zhong, Y., Kumagai, A., Dunphy, W. G., & Chong, S. (2026) · Advanced Science · doi:10.1002/advs.202600048 · Cited by 2
Translocations in Ewing Sarcoma
Tanner, J. M., & Lessnick, S. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_15 · Cited by 2
Self-citationBayanjargal, A., Taslim, C., Showpnil, I. A., Selich‐Anderson, J., Crow, J. C., Zhou, R., Lessnick, S. L., & Theisen, E. R. (2026) · eLife · doi:10.7554/elife.95626.4 · Cited by 3
Self-citationSubcellular localization of pro-gastrin releasing peptide in human Ewing sarcoma cell lines
Muramatsu, K., Maruyama, K., Honda, Y., Katagiri, H., Takahashi, Y., Takahashi, N., Aoyagi, K., Mori, K., Takahashi, M., Kameya, T., et al. (2025) · Medical Molecular Morphology · doi:10.1007/s00795-025-00426-2 · Cited by 1
Tirode, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00022-4 · Cited by 1
Pediatric malignancies: update on sarcomas and leukemia development in children
Braun, B. S., & Lessnick, S. L. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.005 · Cited by 1
“Even more recently, chromatin immunoprecipitation (ChIP) approaches (ChIP-cloning and ChIP-chip) have been used to identify target genes that are bound by EWSFLI itself, and by its targets [19 ,20].”
MethodSelf-citationHubbard, A. K., Neyret‐Kahn, H., Müller‐Nurasyid, M., Löw, D., Strauch, K., Lee, O. W., Raduski, A. R., Yang, T., Zhou, W., Stratton, E., et al. (2026) · medRxiv · doi:10.64898/2026.02.06.26345779 · Cited by 2
“Some of these germline susceptibility loci modulate EWSR1::FLI1 activity through variation in GGAA-mSat length 8,16 , resulting in altered EWSR1::FLI1 binding affinity and downstream dysregulation of local gene expression.”
Scotlandi, K. (2013) · Springer eBooks · doi:10.1007/978-3-319-01748-8_48
Microarrays in Molecular Profiling of Ewing Sarcoma Family of Tumors and CDKN2A Aberrations
Savola, S. P. (2009) · Helda - University of Helsinki Institutional Repository
Fusion protein guided by Sat Nav
Barry, I. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2473
ChIP-ping Away at EWS/ETS Transcription Networks
Denny, C. T. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.016
“This observation, first made by Gangwal et al. (2008), prompted a fundamental mechanistic insight into the relative susceptibility of developing Ewing sarcoma.”
BackgroundLessnick, L., Randall, R. L., Beckerle, M. C., Tanner, J. M., & Bell, R. N. (2014)
Funktionelle Genomik des Ewing‑Sarkoms
Grünewald, T. G. P. (2017) · Der Pathologe · doi:10.1007/s00292-017-0332-7 · Cited by 1
FATE1: Contributor to Tumor Cell Fitness and Example of an Oncogene-Activated Cancer Testis Antigen
Taus, P. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/6ww8-8048
Fusion and Wildtype Proteins of EWSR1 Interact in a Protein Granule
Ahmed, N. S. (2020) · UA Campus Repository (The University of Arizona)
Molecular aspects of Ewing's sarcomas
Tirode, F., & Grünewald, T. G. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00022-0
HOXD13 is a direct EWS-FLI1 target and moderates fusion-dependent transcriptional statesPreprint
Apfelbaum, A. A., Wu, F., Magnuson, B., Hawkins, A. G., Jiménez, J. A., Taylor, S. D., Pfaltzgraff, E. R., Song, J. Y., Hall, C., Wellik, D. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.31.478548
“Functioning as a pioneer 79 factor, EWS-FLI1 creates de novo enhancers at GGAA microsatellite repeats throughout 80 the genome, resulting in aberrant activation of normally heterochromatic regions and 81 widespread transcriptional rewiring (6-10).”
BackgroundCardona, A. F., Zuluaga, J. A., Carranza, H., Otero, J. M., Vargas, C., & Ortiz, L. D. (2014) · Springer eBooks · doi:10.1007/978-94-017-8754-3_12
de Stefani, R. R., de Toni, E. C., de Farias, C. B., Brunetto, A. T., Brunetto, A. L., Roesler, R., Alho, C. S., & Friedrich, D. C. (2022) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2022v68n2.2350
Lessnick, S. L. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718185765.793487793
Self-citationScotlandi, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-29676-6_40
Cardona, A. F., Zuluaga, J. A., Carranza, H., Otero, J. M., & Vargas, C. (2012) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.321
Showpnil, I. A., Miller, K. R., Taslim, C., Pishas, K. I., Lessnick, S. L., & Theisen, E. R. (2020) · Journal of Visualized Experiments · doi:10.3791/61564-v
Self-citationKinsey, M., Smith, R., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2023) · doi:10.1158/0008-5472.c.6500123.v1
Self-citationKinsey, M., Smith, R., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2023) · doi:10.1158/0008-5472.22382174
Self-citationHeisey, D. A. R., Jacob, S., Lochmann, T. L., Kurupi, R., Ghotra, M. S., Calbert, M. L., Shende, M., Maves, Y. K., Koblinski, J. E., Dozmorov, M. G., et al. (2023) · doi:10.1158/1535-7163.c.6542887
Heisey, D. A. R., Jacob, S., Lochmann, T. L., Kurupi, R., Ghotra, M. S., Calbert, M. L., Shende, M., Maves, Y. K., Koblinski, J. E., Dozmorov, M. G., et al. (2023) · doi:10.1158/1535-7163.22521043
Chimeric protein EWS-FLI1 drives cell proliferation in Ewing Sarcoma via overexpression of KCNN1Preprint
Dupuy, M., Guéguinou, M., Postec, A., Brion, R., Tesfaye, R. A., Mullard, M., Regnier, L., Amiaud, J., Potier‐Cartereau, M., Chantôme, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.24.538050
“It has also been proved that EWS-FLI1 is able to bind GGAA microsatellites (Gangwal et al, 2008; Guillon et al, 2009), which can be repeated up to 20 times.”
BackgroundJain, K., Henrich, I. C., Quick, L., Young, R., Mondal, S., Oliveira, A. M., Blobel, G. A., & Chou, M. M. (2023) · doi:10.1158/2767-9764.c.6760503
Bayanjargal, A., Taslim, C., Showpnil, I. A., Selich‐Anderson, J., Crow, J. C., Lessnick, S. L., & Theisen, E. R. (2024) · eLife · doi:10.7554/elife.95626.1
Self-citationBayanjargal, A., Taslim, C., Showpnil, I. A., Selich‐Anderson, J., Crow, J. C., Zhou, R., Lessnick, S. L., & Theisen, E. R. (2026) · eLife · doi:10.7554/elife.95626 · Cited by 5
Self-citationHölting, T. L. B., Cidre‐Aranaz, F., Matzek, D., Popper, B., Jacobi, S. J., Funk, C. M., Geyer, F. H., Li, J., Piseddu, I., Cadilha, B. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21332792
Bayanjargal, A., Taslim, C., Showpnil, I. A., Selich‐Anderson, J., Crow, J. C., Zhou, R., Lessnick, S. L., & Theisen, E. R. (2024) · eLife · doi:10.7554/elife.95626.2.sa0
Self-citationNR0B1 alters the 9- cis -retinoic acid response in Ewing Sarcoma cellsPreprint
Sunkel, B. D., Wang, M., Dreher, R. D., Sammons, M. C., Ryan, L., Gross, A. C., Friedland, S., Roberts, R. D., Theisen, E. R., Mardis, E. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.679070
“It may be of interest to consider these sites as important nodes in the network of regulatory elements driving NR0B1 expression in addition to the previously reported proximal GGAA microsatellite repeat [19, 20].”
Hölting, T. L. B., Cidre‐Aranaz, F., Matzek, D., Popper, B., Jacobi, S. J., Funk, C. M., Geyer, F. H., Li, J., Piseddu, I., Cadilha, B. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21332795
Hölting, T. L. B., Cidre‐Aranaz, F., Matzek, D., Popper, B., Jacobi, S. J., Funk, C. M., Geyer, F. H., Li, J., Piseddu, I., Cadilha, B. L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21332786
Truong, D. D., Lamhamedi-Cherradi, S.-E., Porter, R. W., Krishnan, S., Swaminathan, J., Gibson, A., Lazar, A. J., Livingston, J. A., Gopalakrishnan, V., Gordon, N. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26593043
Bayanjargal, A., Taslim, C., Showpnil, I. A., Selich‐Anderson, J., Crow, J. C., Zhou, R., Lessnick, S. L., & Theisen, E. R. (2026) · eLife · doi:10.7554/elife.95626.3 · Cited by 1
Self-citationSynthetic Lethality and Metabolism in Ewing Sarcoma : Knowledge Through Silence
Jonker, A. H. (2014) · theses.fr (ABES) · doi:10.70675/7e4efaeazcdf1z4e21zacfdza6f20813ef10 · Cited by 2
Integrative characterization of oncogenesis and immune response in sarcoma
Vibert, J. (2021) · theses.fr (ABES) · doi:10.70675/9edc56aaza4d7z40daz97ebz89075c1945ac · Cited by 1
Peterson, S. K., Massie, A. M., Rubinsteyn, A., Wang, J., & Davis, I. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.08.717017
“GGAA microsatellites targeted by the EWS-506 FLI1 fusion oncoprotein function as regulatory elements and repeat architecture influences chromatin accessibility and transcription factor binding (Gangwal et al. 2008; Riggi et al. 2014).”
EWSR1::FLI1 promotes neocentromere formation in ewing sarcoma cells
Kitagawa, R., Metitiri, E. E., Yu, B., Shen, C., Bishop, A. J. R., Zheng, S., Houghton, P. J., & Kitagawa, K. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117846
Feng, S., Feng, M., Lu, Z., Shen, J., & Xia, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1959848
“In prostate cancer with ERG fusion, HIST1H4L expression is speci fi cally upregulated and is considered a potential downstream target of the ERG fusion, although its precise oncogenic mechanism remains unclear (9, 10).”
Ancient and animal-specific regulatory modes of EWS::FLI1 revealed by a minimal yeast model
Velázquez, D., Molnar, C., Reina, J., Mora, J., & González, C. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag329
“…are associated with these elements, and that GGAA μ Sats-driven ectopic enhancers can influence both proximal and distal genes (10, 13), it is widely accepted that activation of GGAA μ Sats represents the primary mechanism by which EWS::FLI1 directly dysregulates gene expression (8 – 10, 12, 17).”
InfluentialA Practical Compass to Biological Digital Resources and Omics Integration in Ewing Sarcoma
Henon, C., Koster, J., Waterfall, J. J., & Grünewald, T. G. P. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5587-0_26
Epigenetic Analysis in Ewing Sarcoma
Urzì, O., Stelzer, T., Sims, J., & Tomazou, E. M. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5587-0_28
A Drosophila Study Model for EWS::FLI1-Induced Molecular Pathways
Molnar, C., Mora, J., & González, C. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5587-0_25
Chromatin Immunoprecipitation Followed by Next-Generation Sequencing in Ewing Sarcoma
Táboas, P., Blanco, E., Croce, L. D., & Sánchez-Molina, S. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5587-0_27
Spatial neighborhood organization shapes clinical heterogeneity in Ewing sarcomaPreprint
Luo, H., Henon, C., Rukhovich, G. D., Ranft, A., Kutschmann, S., Wilhelm, N., Jabar, S., Koch, L., Rutz, S. P., Mathioudaki, A., et al. (2026) · medRxiv · doi:10.64898/2026.10.24.26366384
Exploiting iron metabolism in Ewing sarcoma
Hayes, C. M., & Theisen, E. R. (2026) · Communications Medicine · doi:10.1038/s43856-026-01954-3
Tang, L., 周浩玲, & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1962178
Metadata
- Authors
- Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., & Lessnick, S. L.
- Affiliations
- University of Utah (US)
- Huntsman Cancer Institute (US)
- Department of Human Genetics,
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-07-22
- Volume
- 105
- Issue
- 29
- Pages
- 10149-10154
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2481306
- OpenAlex
- W2027899965
- Cited by
- 297
- References
- 30
- Citations by year
- 2026: 19 · 2025: 18 · 2024: 24 · 2023: 23 · 2022: 24 · 2021: 19 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 14 · 2016: 12 · 2015: 11 · 2014: 13 · 2013: 12 · 2012: 16
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Huntsman Cancer Foundation
- Huntsman Cancer Institute
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL070048)
- National Cancer Institute (K08CA096755, P30CA042014)
- National Institute of General Medical Sciences (R01GM038663, R01GM059290)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- Ewing sarcoma, ETS transcription factors, microsatellite markers, transcription factor target genes, NR0B1, promoter binding, chromosomal translocation, gene expression regulation
- MeSH terms
- Base Sequence, DNA, Neoplasm, Humans, Molecular Sequence Data, Sarcoma, Ewing, Transcription Factors, Transfection, Oncogene Proteins, Fusion, Microsatellite Repeats, Response Elements, RNA-Binding Protein EWS, Cell Line, Tumor, Chromatin Immunoprecipitation, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.